MarketAnalysisMarketAnalysis
NASDAQ:FBRX

Forte Biosciences, Inc. - NASDAQ:FBRX - Comprehensive analysis

Free evaluation through quantitative algorithms Forte Biosciences, Inc. - NASDAQ:FBRX

Quant Rating

1

Strong Sell

2

Sell

3

Hold

4

Buy

5

Strong Buy


The overall quant rating is not an average of the factor grades listed.Instead, it gives greater weight to the metrics with the strongest predictive value.

Growth-Scoring Model Detail

Name

Fatcor
Percentage

Total Revenue Growth Over Prior Year

0

Market

30

Sector

40

Gross Profit Growth Over Prior Year

0

Market

25

Sector

40

EBITDA Growth Over Prior Year

0

Market

32

Sector

45

EBITA Growth Over Prior Year

0

Market

0

Sector

0

EBIT Growth Over Prior Year

0

Market

0

Sector

0

Earnings from Cont. Ops. Growth Over Prior Year

0

Market

0

Sector

0

Net Income Growth Over Prior Year

0

Market

0

Sector

0

Normalized Net Income Growth Over Prior Year

0

Market

0

Sector

0

Diluted EPS before Extra Growth Over Prior Year

0

Market

0

Sector

0

A/R Growth Over Prior Year

0

Market

35

Sector

43

Inventory Growth Over Prior Year

0

Market

62

Sector

48

PPE Net Growth Over Prior Year

-12.24

Market

3

Sector

36

Total Assets Growth Over Prior Year

-62.52

Market

1

Sector

5

Tangible Book Value Growth Over Prior Year

-76.82

Market

1

Sector

5

Common Equity Growth Over Prior Year

-76.82

Market

0

Sector

5

Cash from Ops. Growth Over Prior Year

0

Market

0

Sector

0

CAPEX Growth Over Prior Year

-67.61

Market

1

Sector

22

Dividend per Share Growth Over Prior Year

0

Market

35

Sector

49

Levered Free Cash Flow Growth Over Prior Year

0

Market

0

Sector

0

Unlevered Free Cash Flow Growth Over Prior Year

0

Market

0

Sector

0

Profitability-Scoring Model Detail

Name

Fatcor
Percentage

Gross Margin %

0

Market

5

Sector

27

SG&A Margin %

0

Market

7

Sector

15

EBITDA Margin %

0

Market

2

Sector

52

EBITA Margin %

0

Market

7

Sector

54

EBIT Margin %

0

Market

3

Sector

56

Earnings from Cont. Ops Margin %

0

Market

6

Sector

61

Net Income Margin %

0

Market

6

Sector

62

Net Income Avail. for Common Margin %

0

Market

6

Sector

62

Normalized Net Income Margin %

0

Market

2

Sector

59

Levered Free Cash Flow Margin %

0

Market

21

Sector

51

Unlevered Free Cash Flow Margin %

0

Market

19

Sector

49

Return on Assets %

-67.66

Market

0

Sector

13

Return on Capital %

-89.48

Market

0

Sector

13

Return on Equity %

-137.4

Market

0

Sector

21

Return on Common Equity %

-137.4

Market

0

Sector

22

Total Asset Turnover

0

Market

5

Sector

15

Sub-Scoring Model

Valuation
Momentum
Growth
Profitability
80
60
40
20
Valuation: 95
Momentum: 29
Growth: 20
Profitability: 6

Valuation-Scoring Model Detail

Name

Fatcor
Percentage

TEV/LTM Total Revenue

0

Market

0

Sector

0

TEV/LTM EBITDA

0.14

Market

0

Sector

9

P/LTM Normalized EPS

0

Market

0

Sector

0

P/BV

1.02

Market

6

Sector

34

TEV/LTM Unlevered FCF

0.33

Market

0

Sector

10

Momentum-Scoring Model Detail

Name

Fatcor
Percentage

1M Price Performance

-3.62

Market

53

Sector

74

3M Price Performance

-65.06

Market

0

Sector

8

6M Price Performance

16.22

Market

91

Sector

86

9M Price Performance

-59.03

Market

2

Sector

31

1Y Price Performance

-68.94

Market

1

Sector

29

Start analyzing Forte Biosciences, Inc. - NASDAQ:FBRX with easy-to-understand research reports

Start analyzing Recent popular companies with easy-to-understand research reports